These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 11364904)
1. Expanded access to experimental drugs: activists seek more open programs. Grinberg L AIDS Treat News; 1997 Nov; (No 282):6-7. PubMed ID: 11364904 [TBL] [Abstract][Full Text] [Related]
2. The fuss over 1592. Vazquez E Posit Aware; 1997; 8(5):26-7. PubMed ID: 11364637 [TBL] [Abstract][Full Text] [Related]
3. 1592 access: larger program planned. Grinberg L; James JS AIDS Treat News; 1997 Nov; (No 283):2-3. PubMed ID: 11364908 [TBL] [Abstract][Full Text] [Related]
11. Whatever happened to expanded access? Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564 [TBL] [Abstract][Full Text] [Related]
12. Amprenavir (Agenerase) now available in expanded access. AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864 [TBL] [Abstract][Full Text] [Related]
13. Abacavir at last. Gilden D GMHC Treat Issues; 1998 Mar; 12(3):9. PubMed ID: 11365394 [TBL] [Abstract][Full Text] [Related]
17. New expanded access drugs for use in combination therapy. Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085 [TBL] [Abstract][Full Text] [Related]
18. Drifting agenda for federal treatment research. Huff B GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299 [No Abstract] [Full Text] [Related]
19. Moving forward: a treatment overview from the 12th World AIDS Conference. Agosto M Newsline People AIDS Coalit N Y; 1998 Sep; ():6-11. PubMed ID: 11367497 [TBL] [Abstract][Full Text] [Related]